November 10, 2009Open Access

Major Lipids, Apolipoproteins, and Risk of Vascular Disease

Key Points

Key points are not available for this paper at this time.

Abstract

Lipid assessment in vascular disease can be simplified by measurement of either total and HDL cholesterol levels or apolipoproteins without the need to fast and without regard to triglyceride.

KI fragen

Bookmark

View Full Paper

Cite This Study

Emanuele Di Angelantonio (Tue,) studied this question.

synapsesocial.com/papers/69d7ba8a3b601d7be3ae298e https://doi.org/https://doi.org/10.1001/jama.2009.1619

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)2001 · 26,017 citations
2Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge1972 · 32,502 citations
3Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis2009 · 41 citations
4Drug Treatment of Lipid Disorders1999 · 849 citations
5Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27 247 adults in 15 prospective studies2006 · 97 citations

KI fragen

Bookmark

View Full Paper